logo
logo
Sign in

Low dose Naltrexone as a treatment for Chronic Fatigue Syndrome

avatar
Harborcompounding Pharmacy
Low dose Naltrexone as a treatment for Chronic Fatigue Syndrome

Low Dose Naltrexone, a synthetic drug popular for its anti-opioid action, is also getting famous for its extensive usage and mode of action at opioid and non-opioid receptors. At present, Low dose Naltrexone is a licensed drug that can be used to treat alcoholism and opioid addiction at a specific dose of 50 mg. But it is also an emerging choice of medicine that can be utilized as an immune modulator, and for suppressing tumor growths, specifically at lower doses of around 3-4.5 mg. These low doses of Naltrexone are depicted as low-dose Naltrexone or LDN. Furthermore, the immune system can be modulated with the aid of LDN by changing the body's endorphin levels. The body's inflammatory responses can be decreased by increasing endorphin levels, which is how LDN works.

Literature Review

CFS/ME is a medical condition where the physical and cognitive functions of the body are affected badly. Unfortunately, so far, no known medical treatment is available. However, ongoing medical research has supported the use of LDN, where the safety and effectiveness of LDN have been studied in clinical setups. According to a report, 73.9% of patients responded positively to treatment with LDN. Alertness and activeness were reported by most of the patients. Some of them also reported better physical and cognitive outcomes. Pain and fever relief was also reported by patients. So far, no rigorous or long-term side effects have been reported. The treatment response frequency was high, along with a good safety window. These demonstrative clinical studies are sources of hope for patients with severe symptoms when they are helpless and in pain. 

collect
0
avatar
Harborcompounding Pharmacy
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more